Tempus AI EBIT 2023-2024 | TEM

Tempus AI annual and quarterly EBIT history from 2023 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Tempus AI EBIT for the quarter ending September 30, 2024 was $-0.054B, a 19.71% increase year-over-year.
  • Tempus AI EBIT for the twelve months ending September 30, 2024 was $-0.762B, a 429.97% increase year-over-year.
  • Tempus AI 2023 annual EBIT was $-0.265B, a 35.37% increase from 2022.
  • Tempus AI 2022 annual EBIT was $-0.196B, a INF% decline from .
  • Tempus AI annual EBIT was $0B, a NAN% decline from .
Tempus AI Annual EBIT
(Millions of US $)
2023 $-265
2022 $-196
Tempus AI Quarterly EBIT
(Millions of US $)
2024-09-30 $-54
2024-06-30 $-533
2024-03-31 $-53
2023-12-31 $-122
2023-09-30 $-45
2023-06-30 $-45
2023-03-31 $-54
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $11.384B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.892B 183.76
Hims & Hers Health (HIMS) United States $5.028B 130.06
Axonics (AXNX) United States $3.600B 1760.50
IRhythm Technologies (IRTC) United States $2.707B 0.00
Enovis (ENOV) United States $2.594B 17.58
Privia Health (PRVA) United States $2.547B 213.00
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Clover Health Investments (CLOV) United States $1.696B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Fulgent Genetics (FLGT) United States $0.589B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00